Dissecting the Role of Immune Checkpoint Regulation Patterns in Tumor Microenvironment and Prognosis of Gastric Cancer

被引:3
作者
Zhen, Zili
Shen, Zhemin
Sun, Peilong
机构
[1] Department of General Surgery, Jinshan Hospital, Fudan University, Shanghai
[2] Department of Surgery, Shanghai Medical College, Fudan University, Shanghai
[3] Center for Tumor Diagnosis and Therapy, Jinshan Hospital, Fudan University, Shanghai
关键词
gastric cancer; immune checkpoint; tumor microenvironment; immunotherapy; prognosis; GASTROESOPHAGEAL JUNCTION CANCER; T-CELLS; EXPRESSION; IMMUNOTHERAPY; STRATEGIES; PATHWAY; FAMILY;
D O I
10.3389/fgene.2022.853648
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Many studies suggest that immune checkpoint molecules play a vital role in tumor progression and immune responses. However, the impact of the comprehensive regulation pattern of immune checkpoint molecules on immune responses, tumor microenvironment (TME) formation, and patient prognosis is poorly understood. In this study, we evaluated immune checkpoint regulation patterns in 1,174 gastric cancer (GC) samples based on 31 immune checkpoint genes (ICGs). Three distinct immune checkpoint regulation patterns with significant prognostic differences were ultimately identified. Moreover, GC patients were divided into two subgroups according to immune checkpoint score (ICscore). Patients with lower ICscore were characterized by a favorable prognosis and enhanced immune infiltration as well as an increased tumor mutation burden, non-recurrence, and microsatellite instability-high. Collectively, this study indicated that immune checkpoint regulation patterns were essential to forming the diversity of TME and a better understanding of that will contribute to assessing the characteristics of TME in GC, which intends to improve the development of immunotherapy.
引用
收藏
页数:13
相关论文
共 48 条
[1]   Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance [J].
Bagchi, Sreya ;
Yuan, Robert ;
Engleman, Edgar G. .
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 16, 2021, 2021, 16 :223-249
[2]   Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 [J].
Barbie, David A. ;
Tamayo, Pablo ;
Boehm, Jesse S. ;
Kim, So Young ;
Moody, Susan E. ;
Dunn, Ian F. ;
Schinzel, Anna C. ;
Sandy, Peter ;
Meylan, Etienne ;
Scholl, Claudia ;
Froehling, Stefan ;
Chan, Edmond M. ;
Sos, Martin L. ;
Michel, Kathrin ;
Mermel, Craig ;
Silver, Serena J. ;
Weir, Barbara A. ;
Reiling, Jan H. ;
Sheng, Qing ;
Gupta, Piyush B. ;
Wadlow, Raymond C. ;
Le, Hanh ;
Hoersch, Sebastian ;
Wittner, Ben S. ;
Ramaswamy, Sridhar ;
Livingston, David M. ;
Sabatini, David M. ;
Meyerson, Matthew ;
Thomas, Roman K. ;
Lander, Eric S. ;
Mesirov, Jill P. ;
Root, David E. ;
Gilliland, D. Gary ;
Jacks, Tyler ;
Hahn, William C. .
NATURE, 2009, 462 (7269) :108-U122
[3]   Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade [J].
Charoentong, Pornpimol ;
Finotello, Francesca ;
Angelova, Mihaela ;
Mayer, Clemens ;
Efremova, Mirjana ;
Rieder, Dietmar ;
Hackl, Hubert ;
Trajanoski, Zlatko .
CELL REPORTS, 2017, 18 (01) :248-262
[4]   Elements of cancer immunity and the cancer-immune set point [J].
Chen, Daniel S. ;
Mellman, Ira .
NATURE, 2017, 541 (7637) :321-330
[5]   Development and validation of a prognostic and predictive 32-gene signature for gastric cancer [J].
Cheong, Jae-Ho ;
Wang, Sam C. ;
Park, Sunho ;
Porembka, Matthew R. ;
Christie, Alana L. ;
Kim, Hyunki ;
Kim, Hyo Song ;
Zhu, Hong ;
Hyung, Woo Jin ;
Noh, Sung Hoon ;
Hu, Bo ;
Hong, Changjin ;
Karalis, John D. ;
Kim, In-Ho ;
Lee, Sung Hak ;
Hwang, Tae Hyun .
NATURE COMMUNICATIONS, 2022, 13 (01)
[6]   THE TNF FAMILY OF LIGANDS AND RECEPTORS: COMMUNICATION MODULES IN THE IMMUNE SYSTEM AND BEYOND [J].
Dostert, Catherine ;
Grusdat, Melanie ;
Letellier, Elisabeth ;
Brenner, Dirk .
PHYSIOLOGICAL REVIEWS, 2019, 99 (01) :115-160
[7]   The Reactome Pathway Knowledgebase [J].
Fabregat, Antonio ;
Jupe, Steven ;
Matthews, Lisa ;
Sidiropoulos, Konstantinos ;
Gillespie, Marc ;
Garapati, Phani ;
Haw, Robin ;
Jassal, Bijay ;
Korninger, Florian ;
May, Bruce ;
Milacic, Marija ;
Roca, Corina Duenas ;
Rothfels, Karen ;
Sevilla, Cristoffer ;
Shamovsky, Veronica ;
Shorser, Solomon ;
Varusai, Thawfeek ;
Viteri, Guilherme ;
Weiser, Joel ;
Wu, Guanming ;
Stein, Lincoln ;
Hermjakob, Henning ;
D'Eustachio, Peter .
NUCLEIC ACIDS RESEARCH, 2018, 46 (D1) :D649-D655
[8]   Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer Phase 2 Clinical KEYNOTE-059 Trial [J].
Fuchs, Charles S. ;
Doi, Toshihiko ;
Jang, Raymond W. ;
Muro, Kei ;
Satoh, Taroh ;
Machado, Manuela ;
Sun, Weijing ;
Jalal, Shadia I. ;
Shah, Manish A. ;
Metges, Jean-Phillipe ;
Garrido, Marcelo ;
Golan, Talia ;
Mandala, Mario ;
Wainberg, Zev A. ;
Catenacci, Daniel V. ;
Ohtsu, Atsushi ;
Shitara, Kohei ;
Geva, Ravit ;
Bleeker, Jonathan ;
Ko, Andrew H. ;
Ku, Geoffrey ;
Philip, Philip ;
Enzinger, Peter C. ;
Bang, Yung-Jue ;
Levitan, Diane ;
Wang, Jiangdian ;
Rosales, Minori ;
Dalal, Rita P. ;
Yoon, Harry H. .
JAMA ONCOLOGY, 2018, 4 (05)
[9]   Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment [J].
Gajewski, Thomas F. ;
Woo, Seng-Ryong ;
Zha, Yuanyuan ;
Spaapen, Robbert ;
Zheng, Yan ;
Corrales, Leticia ;
Spranger, Stefani .
CURRENT OPINION IN IMMUNOLOGY, 2013, 25 (02) :268-276
[10]  
GBD 2017 Stomach Collaborators, 2020, LANCET GASTROENTEROL, V5, P42